These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22096584)

  • 1. Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy.
    Koutsopoulos OS; Koch C; Tosch V; Böhm J; North KN; Laporte J
    PLoS One; 2011; 6(11):e27498. PubMed ID: 22096584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
    Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
    Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamin-2 mutations associated with centronuclear myopathy are hypermorphic and lead to T-tubule fragmentation.
    Chin YH; Lee A; Kan HW; Laiman J; Chuang MC; Hsieh ST; Liu YW
    Hum Mol Genet; 2015 Oct; 24(19):5542-54. PubMed ID: 26199319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
    Tinelli E; Pereira JA; Suter U
    Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common membrane trafficking defects of disease-associated dynamin 2 mutations.
    Liu YW; Lukiyanchuk V; Schmid SL
    Traffic; 2011 Nov; 12(11):1620-33. PubMed ID: 21762456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.
    Sidiropoulos PN; Miehe M; Bock T; Tinelli E; Oertli CI; Kuner R; Meijer D; Wollscheid B; Niemann A; Suter U
    Brain; 2012 May; 135(Pt 5):1395-411. PubMed ID: 22451505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis.
    Bitoun M; Durieux AC; Prudhon B; Bevilacqua JA; Herledan A; Sakanyan V; Urtizberea A; Cartier L; Romero NB; Guicheney P
    Hum Mutat; 2009 Oct; 30(10):1419-27. PubMed ID: 19623537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation associated with centronuclear myopathy enhances the size and stability of dynamin 2 complexes in cells.
    James NG; Digman MA; Ross JA; Barylko B; Wang L; Li J; Chen Y; Mueller JD; Gratton E; Albanesi JP; Jameson DM
    Biochim Biophys Acta; 2014 Jan; 1840(1):315-21. PubMed ID: 24016602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into wild-type dynamin 2 and the consequences of DNM2 mutations from transgenic zebrafish.
    Zhao M; Smith L; Volpatti J; Fabian L; Dowling JJ
    Hum Mol Genet; 2019 Dec; 28(24):4186-4196. PubMed ID: 31691805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
    Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
    Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zebrafish as a Model to Investigate Dynamin 2-Related Diseases.
    Bragato C; Gaudenzi G; Blasevich F; Pavesi G; Maggi L; Giunta M; Cotelli F; Mora M
    Sci Rep; 2016 Feb; 6():20466. PubMed ID: 26842864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlative SICM-FCM reveals changes in morphology and kinetics of endocytic pits induced by disease-associated mutations in dynamin.
    Ali T; Bednarska J; Vassilopoulos S; Tran M; Diakonov IA; Ziyadeh-Isleem A; Guicheney P; Gorelik J; Korchev YE; Reilly MM; Bitoun M; Shevchuk A
    FASEB J; 2019 Jul; 33(7):8504-8518. PubMed ID: 31017801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.
    Böhm J; Biancalana V; Dechene ET; Bitoun M; Pierson CR; Schaefer E; Karasoy H; Dempsey MA; Klein F; Dondaine N; Kretz C; Haumesser N; Poirson C; Toussaint A; Greenleaf RS; Barger MA; Mahoney LJ; Kang PB; Zanoteli E; Vissing J; Witting N; Echaniz-Laguna A; Wallgren-Pettersson C; Dowling J; Merlini L; Oldfors A; Bomme Ousager L; Melki J; Krause A; Jern C; Oliveira AS; Petit F; Jacquette A; Chaussenot A; Mowat D; Leheup B; Cristofano M; Poza Aldea JJ; Michel F; Furby A; Llona JE; Van Coster R; Bertini E; Urtizberea JA; Drouin-Garraud V; Béroud C; Prudhon B; Bedford M; Mathews K; Erby LA; Smith SA; Roggenbuck J; Crowe CA; Brennan Spitale A; Johal SC; Amato AA; Demmer LA; Jonas J; Darras BT; Bird TD; Laurino M; Welt SI; Trotter C; Guicheney P; Das S; Mandel JL; Beggs AH; Laporte J
    Hum Mutat; 2012 Jun; 33(6):949-59. PubMed ID: 22396310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.
    Liewluck T; Lovell TL; Bite AV; Engel AG
    Neuromuscul Disord; 2010 Dec; 20(12):801-4. PubMed ID: 20817456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain-of-Function Properties of a Dynamin 2 Mutant Implicated in Charcot-Marie-Tooth Disease.
    Tassin TC; Barylko B; Hedde PN; Chen Y; Binns DD; James NG; Mueller JD; Jameson DM; Taussig R; Albanesi JP
    Front Cell Neurosci; 2021; 15():745940. PubMed ID: 34744632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.
    Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J
    Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant BIN1-Dynamin 2 complexes dysregulate membrane remodeling in the pathogenesis of centronuclear myopathy.
    Fujise K; Okubo M; Abe T; Yamada H; Nishino I; Noguchi S; Takei K; Takeda T
    J Biol Chem; 2021; 296():100077. PubMed ID: 33187981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a dynamin 2 mutant associated with Charcot-Marie-Tooth disease leads to aberrant actin dynamics and lamellipodia formation.
    Yamada H; Kobayashi K; Zhang Y; Takeda T; Takei K
    Neurosci Lett; 2016 Aug; 628():179-85. PubMed ID: 27328317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamin-2 in nervous system disorders.
    González-Jamett AM; Haro-Acuña V; Momboisse F; Caviedes P; Bevilacqua JA; Cárdenas AM
    J Neurochem; 2014 Jan; 128(2):210-23. PubMed ID: 24102355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic instability of microtubules requires dynamin 2 and is impaired in a Charcot-Marie-Tooth mutant.
    Tanabe K; Takei K
    J Cell Biol; 2009 Jun; 185(6):939-48. PubMed ID: 19528294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.